一个更新的审查,以管理亚托邦皮肤炎的管理
Papapit Tuchinda1, Sira Nanthapisal2, Rattanavalai Nitiyarom3
1Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Asian Pacific journal of allergy and immunology
|February 16, 2026
概括
本综述更新了有关亚托邦性皮炎 (AD) 的知识,亚托邦性皮炎是一种影响全球生活质量的慢性皮肤疾病. 它涵盖了AD患病率,原因,诊断和当前治疗策略,以更好地管理患者.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 亚托皮炎 (AD) 是一种普遍存在的慢性炎症性皮肤疾病.
- 阿尔茨海默病显著影响全球患者的生活质量.
- 泰国皮肤学和儿科协会之间的合作得到了重视.
研究的目的:
- 为了提供有关亚托皮性皮肤炎的最新概述.
- 巩固有关AD流行,病原,诊断和治疗的当前知识.
- 支持医疗保健专业人员管理AD患者.
主要方法:
- 文献综述综合了有关亚托邦性皮肤炎的最新信息.
- 泰国领先医疗协会的合作努力.
主要成果:
- 关于AD流行病学和疾病机制的全面更新.
- 目前对阿尔茨海默病的诊断标准和治疗方法详细说明.
- 强调更新治疗指南的重要性.
结论:
- 定期更新AD知识对于有效管理至关重要.
- 标准化管理协议可以改善患者的治疗结果.
- 这篇评论是管理AD的临床医生的一个重要资源.
相关概念视频
Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-IV: Nursing Management
3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.9K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.9K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.9K
Atherosclerosis III: Management
459
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459
Inflammatory Bowel Disease IV: Pharmacological Management
795
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
795


